Article Text

Electronic cigarette and smoking paraphernalia point of sale displays: an observational study in England
  1. Laura A Brocklebank1,2,
  2. Anna K M Blackwell1,
  3. Theresa M Marteau3,
  4. Katie De-loyde1,
  5. Richard W Morris4,
  6. Thomas Burgoine5,
  7. Alice Hobson3,
  8. Minna Ventsel3,
  9. Marcus R Munafo1
  1. 1 School of Psychological Science, University of Bristol, Bristol, UK
  2. 2 Department of Behavioural Science and Health, University College London, London, UK
  3. 3 Behaviour and Health Research Unit, University of Cambridge, Cambridge, UK
  4. 4 Department of Population Health Sciences, University of Bristol, Bristol, UK
  5. 5 UKCRC Centre for Diet and Activity Research (CEDAR), MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK
  1. Correspondence to Dr Laura A Brocklebank, Department of Behavioural Science and Health, University College London, London, UK; l.brocklebank{at}ucl.ac.uk; Dr Marcus R Munafo, School of Psychological Science, University of Bristol, Bristol, UK; marcus.munafo{at}bristol.ac.uk

Abstract

Background Tobacco point of sale (POS) retail displays are banned in many countries, including in England, due in part to evidence linking them to greater susceptibility to smoking in children. There is no equivalent ban on displays of electronic cigarettes (e-cigarettes) or smoking paraphernalia (eg, cigarette lighters) in England, which are often positioned alongside covered tobacco storage units. This observational study describes the visibility and placement of e-cigarette and smoking paraphernalia POS displays in major tobacco retailers in two cities in England to inform future research examining their possible links to susceptibility to tobacco smoking, particularly in children.

Methods Researchers visited all small- and large-format stores of four supermarket chains and a randomly selected sample of convenience stores, in Bristol and Cambridge. A standardised checklist was used to create a total visibility score for POS displays of (a) e-cigarettes and (b) smoking paraphernalia, plus other measures of visibility and placement. These were described for the total sample and compared between areas of low, medium, and high deprivation using general linear models adjusting for store location and store type.

Results The visibility checklist was completed in 133 of 166 stores (80% completion rate). Both e-cigarette and smoking paraphernalia POS displays were present in 96% of stores. POS displays were highly visible across all stores: mean (SD) total visibility scores, out of 17, were 14.7 (1.8) for e-cigarettes and 12.7 (1.8) for smoking paraphernalia. There was no clear evidence of differences in visibility by area of deprivation.

Conclusion E-cigarette and smoking paraphernalia POS displays are near ubiquitous and highly visible in major tobacco retailers in two cities in England. The impact of these displays on tobacco smoking in children and adults is unknown, meriting urgent research to assess their effect on susceptibility to tobacco smoking in children.

  • advertising and promotion
  • electronic nicotine delivery devices
  • environment
  • socioeconomic status

Data availability statement

The datasets generated and analysed during the current study are available at the University of Bristol data repository, data.bris, at https://doi.org/10.5523/bris.2u6wn87v1hc5a2oltkhmdlfnr3.

This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Introduction

Displays of tobacco products at point of sale (POS) in retail stores (eg, cigarettes, loose tobacco, and heated tobacco), which are linked to increased smoking and greater susceptibility to smoking in children,1 2 are banned in many countries. Between 2001 and 2016, 20 countries implemented tobacco POS display bans,3 including England. Increasingly they are being replaced with tobacco storage units, often positioned alongside tobacco signage and open displays of electronic cigarettes (e-cigarettes) and smoking paraphernalia (eg, cigarette lighters). In 2016, the European Union (EU) Tobacco Products Directive introduced new regulations for e-cigarette retailers,4 prohibiting in retail stores: (1) additional imagery that is not of the product; and (2) overly descriptive language that describes products in a way that cannot be objectively substantiated.5 However, a ban on e-cigarette POS displays similar to tobacco was not introduced.

A balanced approach to e-cigarette sales is required to promote their use as a smoking cessation aid, while avoiding any adverse impacts on non-smokers of product exposure. As manufacturers adapt to the new EU regulations, it is timely to determine whether the more permissive approach to e-cigarette POS displays could adversely impact youth smoking.6–9

E-cigarette POS exposure is associated with vaping,10–12 similar to tobacco POS exposure and smoking. Exposure to a combination of tobacco and e-cigarette advertising, including in retail stores, is associated with higher odds of current tobacco use in young people, compared with exposure to tobacco advertising alone.13 Examination of potential cross-product associations between e-cigarette exposure and smoking is therefore warranted.

At present, the extent of this potential problem is unknown because the visibility and placement of e-cigarette and smoking paraphernalia POS displays in major tobacco retailers has not been described in detail. The current study addresses this gap to inform future research examining the impact of e-cigarette and smoking paraphernalia POS displays on tobacco smoking, particularly in children. We also examined differences in visibility according to area of deprivation, hypothesising that visibility would be higher in more deprived areas.

Methods

Study design

This observational study describes the visibility and placement of e-cigarette and smoking paraphernalia POS displays in major tobacco retailers—small- and large-format supermarkets and convenience stores—in Bristol and Cambridge, England, sampled to include areas varying by deprivation.

Sample

The sample comprised 166 retail stores within a 10 mile radius of the University of Bristol and the University of Cambridge. This included all small- and large-format stores of four supermarket chains in England (n=88; Bristol 61, Cambridge 27), and a randomly selected sample of convenience stores from the same postcode districts (n=78; Bristol 54, Cambridge 24). Convenience store locations were obtained from 2018 Ordnance Survey Points of Interest data.14 Supermarkets and convenience stores were chosen as they account for the majority of the EU tobacco market share (Public Health England, personal communication, November 2019). The initial sample size was based on the DISPLAY study.15 Across 96 retail stores, the mean (SD) visibility score (out of 22) was 15.91 (1.82). Accordingly, 131 stores were required to estimate the true mean visibility score to within 2% of its true value, with 95% confidence. Researchers planned to visit 19 additional stores to allow for 14% refusals,16 resulting in a planned sample size of 150. The sample was later supplemented with 16 small-format supermarkets, resulting in a final sample of 166.

Measures

Primary outcomes

Visibility of POS displays was assessed using a checklist, adapted from the tobacco visibility tool used in the DISPLAY study,15 which provided a total visibility score (range: 0 (low) to 17 (high)) for (a) e-cigarettes and (b) smoking paraphernalia (see online supplemental material).

Secondary outcomes

The checklist also assessed for (a) e-cigarettes and (b) smoking paraphernalia:

  1. Number of display units (1/>1)

  2. Presence of signage (yes/ no);

  3. Presence of visible pricing (yes/no)

  4. Size of the display versus tobacco storage unit (smaller (or separate)/same size or larger).

For e-cigarettes only:

  1. Presence of promotional material (yes/no).

Additional measures

Researchers recorded free-text descriptions for (a) e-cigarettes and (b) smoking paraphernalia:

  1. Presence of other types of signage (tobacco, heated tobacco, and/or other)

  2. Other products with visible pricing (tobacco, heated tobacco, and/or other)

  3. Visibility features (position, size, options, signage, lighting, colours, and/or other)

  4. Position of the display versus tobacco storage unit (above, below, adjacent, in front, shared, multiple positions (or separate)).

For e-cigarettes only:

  1. Types of promotional material (health, price, flavours, and/or other).

Procedure

A researcher approached sales assistants or managers for permission to complete the checklist and to photograph the POS display. The photographs were used to resolve any discrepancies between dual ratings, and to confirm visibility scores.

Data analysis

For each total visibility score, a general linear model was used to assess differences between areas of low, medium, and high deprivation after adjusting for store location (Bristol or Cambridge) and store type (convenience store or supermarket). Data are reported as mean differences (95% CI). As a secondary analysis, an interaction term for deprivation level and store type was added to the model to investigate whether area of deprivation had a different effect in convenience stores than in supermarkets.

For all secondary outcomes, logistic regression was used to assess differences between areas of low, medium, and high deprivation after adjusting for store location and store type. Data are reported as OR (95% CI). Additional measures are presented by deprivation level (online supplemental table S1).

Analyses of both primary outcomes were repeated using a bootstrapping method, using 1000 bootstrap samples, due to deviations from normality in their distributions.17 The results were similar (online supplemental table S2).

Further details of the study methods are presented in the pre-registered protocol (osf.io/xks6d).

Results

Sample characteristics

The final sample included checklist data for 133 of 166 stores (80%; 11% refused permission, 8% excluded (4% permanently closed, 4% not selling e-cigarettes or smoking paraphernalia)). Included stores had similar characteristics to the total sample (online supplemental table S3). Of the included stores, 71% were in Bristol and 29% were in Cambridge; 43% were convenience stores, 40% were small-format supermarkets, and 17% were large-format supermarkets; 33% were in areas of low deprivation, 48% were in areas of medium deprivation, and 19% were in areas of high deprivation.

E-cigarette and smoking paraphernalia visibility for all stores

POS displays were highly visible, particularly for e-cigarettes, across all stores. The mean (SD) total visibility score, out of 17, was 14.7 (1.8) for e-cigarettes and 12.7 (1.8) for smoking paraphernalia (table 1). Notable visibility features for both types of POS display were their position, size, and colour.

Table 1

Visibility of point-of-sale displays for e-cigarettes and smoking paraphernalia in supermarkets and convenience stores: England, November 2019 to February 2020 (n=133).

The use of multiple display units was more common for e-cigarettes (53%) than for smoking paraphernalia (12%). Signage was present in most stores (62%) for e-cigarettes, but not for smoking paraphernalia (5%). Visible pricing was present in most stores (70%) for e-cigarettes, but in 45% for smoking paraphernalia. In the majority of stores, e-cigarette (74%) and smoking paraphernalia (93%) displays were smaller than the tobacco storage unit, and positioned adjacent to it (49% and 50%, respectively). Finally, 53% of stores had some form of promotional material for e-cigarettes, with the most common types involving price (23%), ease of use (15%), and flavours (14%) (online supplemental table S1).

Comparing visibility between areas of low, medium, and high deprivation

Contrary to expectation, there was no clear evidence of differences in the visibility of e-cigarette and smoking paraphernalia POS displays between areas of low, medium, and high deprivation after adjusting for store location and store type (table 2). There was also no clear evidence of an interaction between deprivation level and store type (p=0.72 and p=0.82 for the total visibility score for e-cigarettes and smoking paraphernalia, respectively).

Table 2

Visibility of point-of-sale displays for e-cigarettes and smoking paraphernalia, by deprivation level: England, November 2019 to February 2020 (N=132*).

Discussion

E-cigarette and smoking paraphernalia POS displays were ubiquitous and highly visible across all supermarkets and convenience stores in two cities in England, with no clear evidence of differences by area of deprivation.

The current study builds on previous work on the prevalence of e-cigarette POS displays in Scotland18 to examine the visibility of e-cigarette and smoking paraphernalia POS displays in England. Before implementation of the tobacco POS display ban, tobacco products and tobacco storage units were highly visible across all tobacco retailers in Scotland.15 Product visibility did not differ by area of deprivation, but storage unit visibility was higher in areas of high deprivation than in areas of low deprivation. Implementation of the tobacco POS display ban drastically reduced product visibility, and to a lesser extent storage unit visibility. It also eliminated the socioeconomic difference in storage unit visibility.

Exposure to e-cigarette POS displays is associated with increased vaping,10–12 but any impact of e-cigarette displays on smoking is unknown. Further research should examine whether the visibility of e-cigarette and smoking paraphernalia POS displays has an impact on smoking, thereby undermining the effectiveness of the tobacco POS display ban. In addition, if exposure to e-cigarette or smoking paraphernalia displays is associated with susceptibility to tobacco smoking in children, policymakers may want to expand the current ban.

The size and position of e-cigarette POS displays were the two most common features of product visibility recorded by researchers in the majority of both convenience stores (77% and 97%, respectively) and large-format supermarkets (87% and 96%, respectively). In convenience stores, multiple displays were generally found on the counter at the POS, whereas in large-format supermarkets, large displays were generally found spanning the full length behind separate tobacco kiosks. The availability of many colourful product options were also key features of e-cigarette visibility in approximately three-quarters of both convenience stores and large-format supermarkets. In contrast, the use of e-cigarette-specific signage and display lighting were more common features found in large-format supermarkets (74% and 52%, respectively) compared with convenience stores (56% and 18%, respectively). We did not plan to directly compare visibility features by store type, and these exploratory findings should be interpreted with caution. However, these differences are potentially important—they may appeal to, or deliberately target, different audiences, including young non-smokers and adult smokers. Future studies should consider the impact of different display features on different groups.

Strengths and limitations

To our knowledge, this is the first study to describe the visibility and placement of e-cigarette and smoking paraphernalia POS displays in major tobacco retailers. The use of a standardised measure of visibility—adapted from a comprehensive tobacco visibility tool15—is also a strength. Finally, the use of overt measurement meant that observer recall was supplemented with photographs in the majority (77%) of stores, increasing accuracy.

Including stores from only two cities may limit generalisability of the findings, particularly for convenience stores, given that supermarket chains tend to have standardised layouts. Furthermore, store type may be a mediator, rather than a confounder, of the association between area deprivation and visibility of e-cigarette and smoking paraphernalia POS displays due to store types varying by deprivation level. However, minimally adjusted analyses, which included only deprivation level and store location (and not store type), gave very similar results.

Conclusion

E-cigarette and smoking paraphernalia POS displays are near ubiquitous and highly visible in supermarkets and convenience stores in two cities in England. The impact of these displays on tobacco smoking in children and adults is unknown, meriting urgent research to assess their effect on susceptibility to tobacco smoking in children.

What this paper adds

  • Tobacco point of sale (POS) retail displays are banned in many countries, including in England, due in part to evidence linking them to increased smoking and greater susceptibility to smoking in children.

  • There is no equivalent ban on displays of electronic cigarettes (e-cigarettes) or smoking paraphernalia (eg, cigarette lighters) in England, often positioned alongside covered tobacco storage units.

  • This observational study is the first, to our knowledge, to describe the visibility and placement of e-cigarette and smoking paraphernalia POS displays in major tobacco retailers.

  • Our results show that e-cigarette and smoking paraphernalia POS displays are near ubiquitous and highly visible in supermarkets and convenience stores in two cities in England.

  • The high frequency and visibility of these displays could be undermining the effectiveness of the tobacco POS display ban. Their impact on smoking in children merits urgent attention.

Data availability statement

The datasets generated and analysed during the current study are available at the University of Bristol data repository, data.bris, at https://doi.org/10.5523/bris.2u6wn87v1hc5a2oltkhmdlfnr3.

Ethics statements

Patient consent for publication

Ethics approval

Approved by the Faculty of Science Research Ethics Committee at the University of Bristol (approval code: 96902).

References

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Footnotes

  • Contributors LAB was responsible for study design, data collection, data interpretation, and manuscript writing. AKMB was responsible for study design, data collection, data interpretation, and manuscript review. TMM and MRM were responsible for study design, data interpretation, and manuscript review. KDL and RWM were responsible for study design, data analysis, data interpretation, and manuscript review. TB was responsible for data interpretation and manuscript review. AH and MV were responsible for data collection, data interpretation, and manuscript review.

  • Funding This research was funded in whole, or in part, by the Wellcome Trust (ref: 206853/Z/17/Z). For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. TB was supported by the MRC Epidemiology Unit, University of Cambridge (ref: MC/UU/00006/7).

  • Competing interests There are no competing interests.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.